Moxisylyte

Drug Profile

Moxisylyte

Alternative Names: Erecnos; Moxisylyte hydrochloride; Thymoxamine

Latest Information Update: 08 Nov 2001

Price : $50

At a glance

  • Originator Debat
  • Class Dimethylamines; Peripheral vasodilators; Small molecules
  • Mechanism of Action Alpha adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Market Withdrawal Erectile dysfunction

Most Recent Events

  • 08 Nov 2001 Discontinued-registered for Erectile dysfunction in Europe (Intracavernous)
  • 08 Nov 2001 Withdrawn for Erectile dysfunction in United Kingdom (Intracavernous)
  • 08 Nov 2001 Withdrawn for Erectile dysfunction in France (Intracavernous)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top